Salehi Niloufar, Alqamish Maria, Zarnegar Rasa
Department of Surgery, Division of Endocrine & Minimally Invasive Surgery, Weill Cornell Medical College, New York-Presbyterian Hospital, New York, NY 10128, United States.
World J Gastrointest Surg. 2025 Jan 27;17(1):101326. doi: 10.4240/wjgs.v17.i1.101326.
This study reviews the findings of a recent study by Li , which demonstrated that perioperative chemotherapy benefits patients with diffuse-type gastric cancer compared to surgery alone. Despite potential biases, the study supports the inclusion of perioperative chemotherapy in treatment guidelines. Neoadjuvant and adjuvant chemotherapy may also provide similar survival outcomes, allowing for flexible treatment planning.
本研究回顾了李近期的一项研究结果,该研究表明,与单纯手术相比,围手术期化疗对弥漫型胃癌患者有益。尽管存在潜在偏差,但该研究支持将围手术期化疗纳入治疗指南。新辅助化疗和辅助化疗也可能提供相似的生存结果,从而允许进行灵活的治疗规划。